Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pleiner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Wiener Klinische Wochenschrift|October 18, 2001
Train your endotheliumJ Pleiner, M Wolzt
Intensive Care Medicine|June 23, 2009
Research ethics committees in Europe: trials and tribulationsChristiane Druml, M Wolzt, J Pleiner, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2008
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humansG Schaller, J Kolodjaschna, J Pleiner, et al.
European Journal of Clinical Investigation|August 20, 2003
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humansF Mittermayer, J Pleiner, G Schaller, et al.
European Journal of Clinical Investigation|January 7, 2010
Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trialB B Heinisch, M Francesconi, F Mittermayer, et al.
Journal of Human Hypertension|January 11, 2003
Endogenously and exogenously increased noradrenaline exerts sex-different responses in humanM Bayerle-Eder, F Mittermayer, J Pleiner, et al.
Diabetes & Metabolism|January 27, 2005
Effect of systemic vitamin C on free fatty acid-induced lipid peroxidationM Bayerle-Eder, J Pleiner, F Mittermayer, et al.
Diabetologia|July 11, 2002
Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetesG Fuchsjäger-Mayrl, A Kautzky-Willer, B Kiss, et al.
European Journal of Clinical Investigation|April 16, 2002
Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humansM Bayerle-Eder, H Langenberger, J Pleiner, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 10, 2000
Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humansM Bayerle-Eder, M Wolzt, E Polska, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Wiener Klinische Wochenschrift|October 18, 2001
Train your endotheliumJ Pleiner, M Wolzt
Intensive Care Medicine|June 23, 2009
Research ethics committees in Europe: trials and tribulationsChristiane Druml, M Wolzt, J Pleiner, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2008
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humansG Schaller, J Kolodjaschna, J Pleiner, et al.
European Journal of Clinical Investigation|August 20, 2003
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humansF Mittermayer, J Pleiner, G Schaller, et al.
European Journal of Clinical Investigation|January 7, 2010
Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trialB B Heinisch, M Francesconi, F Mittermayer, et al.
Journal of Human Hypertension|January 11, 2003
Endogenously and exogenously increased noradrenaline exerts sex-different responses in humanM Bayerle-Eder, F Mittermayer, J Pleiner, et al.
Diabetes & Metabolism|January 27, 2005
Effect of systemic vitamin C on free fatty acid-induced lipid peroxidationM Bayerle-Eder, J Pleiner, F Mittermayer, et al.
Diabetologia|July 11, 2002
Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetesG Fuchsjäger-Mayrl, A Kautzky-Willer, B Kiss, et al.
European Journal of Clinical Investigation|April 16, 2002
Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humansM Bayerle-Eder, H Langenberger, J Pleiner, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 10, 2000
Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humansM Bayerle-Eder, M Wolzt, E Polska, et al.
Pageof 2